Cdx2 Antibodies

Santa Cruz Biotechnology offers a broad range of Cdx2 monoclonal antibodies for research focused on understanding Cdx2 protein function. Cdx2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdx2 is a critical transcription factor involved in the regulation of intestinal development and differentiation. It plays a significant role in maintaining the integrity of the intestinal epithelium and is essential for proper gut function. Dysregulation of Cdx2 has been implicated in various gastrointestinal diseases, making it an important target for research in developmental biology and pathology. Cdx2 expression patterns serve as valuable markers for studying intestinal metaplasia and various cancers. Researchers can utilize Cdx2 monoclonal antibodies to explore cellular differentiation pathways and tissue-specific gene expression. Understanding Cdx2 regulation mechanisms provides insights into embryonic development and tissue homeostasis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of Cdx2's role in development, disease, and potential therapeutic applications.